[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Yu Bo\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100505493","long-term-follow-up-in-patients-with-acute-myocardial-infarction-cohort-100505493",false,"NCT05862103","Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort","Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort - a Prospective, Multicenter Study","Inclusion Criteria:\n\n* AMI survivors who participated in the project \"Construction and key technology research of the whole myocardial protection system for acute myocardial infarction\" and completed the 1-year visit.\n* Telephone to obtain informed consent from the subjects\u002Ffamily members of the subjects.\n\nExclusion Criteria:\n\n* Not available","ALL","18 Years",{"count":19,"type":20},15000,"ESTIMATED","OBSERVATIONAL","AMI Survivors who participated in the project \"Construction and key technology research of the whole myocardial protection system for acute myocardial infarction\" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.",[24,25],"Acute Myocardial Infarction","Adverse Event",[27,28,29],"Acute myocardial infarction","Major adverse cardiac and cerebrovascular event","Optimized treatment","RECRUITING","2025-08-31",{"date":33,"type":34},"2025-09-03","ACTUAL",{"date":36,"type":34},"2022-12-21",{"date":38,"type":20},"2026-12-30",{"name":40,"class":41},"Yu Bo","OTHER",18,""]